These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23942627)

  • 1. Early surfactant guided by lamellar body counts on gastric aspirate in very preterm infants.
    Verder H; Ebbesen F; Fenger-Grøn J; Henriksen TB; Andreasson B; Bender L; Bertelsen A; Björklund LJ; Dahl M; Esberg G; Eschen C; Høvring M; Kreft A; Kroner J; Lundberg F; Pedersen P; Reinholdt J; Stanchev H
    Neonatology; 2013; 104(2):116-22. PubMed ID: 23942627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity.
    Klebermass-Schrehof K; Wald M; Schwindt J; Grill A; Prusa AR; Haiden N; Hayde M; Waldhoer T; Fuiko R; Berger A
    Neonatology; 2013; 103(4):252-8. PubMed ID: 23446061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates.
    Dunn MS; Kaempf J; de Klerk A; de Klerk R; Reilly M; Howard D; Ferrelli K; O'Conor J; Soll RF;
    Pediatrics; 2011 Nov; 128(5):e1069-76. PubMed ID: 22025591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial.
    Kandraju H; Murki S; Subramanian S; Gaddam P; Deorari A; Kumar P
    Neonatology; 2013; 103(2):148-54. PubMed ID: 23235135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.
    Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T
    N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial.
    Kribs A; Roll C; Göpel W; Wieg C; Groneck P; Laux R; Teig N; Hoehn T; Böhm W; Welzing L; Vochem M; Hoppenz M; Bührer C; Mehler K; Stützer H; Franklin J; Stöhr A; Herting E; Roth B;
    JAMA Pediatr; 2015 Aug; 169(8):723-30. PubMed ID: 26053341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial.
    Sandri F; Ancora G; Lanzoni A; Tagliabue P; Colnaghi M; Ventura ML; Rinaldi M; Mondello I; Gancia P; Salvioli GP; Orzalesi M; Mosca F
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F394-8. PubMed ID: 15321956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term respiratory outcome of late preterm newborn in a center of level III].
    Champion V; Durrmeyer X; Dassieu G
    Arch Pediatr; 2010 Jan; 17(1):19-25. PubMed ID: 19910172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.
    Verder H; Albertsen P; Ebbesen F; Greisen G; Robertson B; Bertelsen A; Agertoft L; Djernes B; Nathan E; Reinholdt J
    Pediatrics; 1999 Feb; 103(2):E24. PubMed ID: 9925870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant Need by Gestation for Very Preterm Babies Initiated on Early Nasal CPAP: A Danish Observational Multicentre Study of 6,628 Infants Born 2000-2013.
    Wiingreen R; Greisen G; Ebbesen F; Petersen JP; Zachariassen G; Henriksen TB; Mølholm Hansen B
    Neonatology; 2017; 111(4):331-336. PubMed ID: 28073106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome.
    Sai Sunil Kishore M; Dutta S; Kumar P
    Acta Paediatr; 2009 Sep; 98(9):1412-5. PubMed ID: 19523049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.